Fish oil lowers insulin resistance in non‑obese rats
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- FAPESP funded the study, which was published in the journal Nutrients.
- Goto‑Kakizaki rats, a standard model for non‑obese type 2 diabetes, were used to test the intervention.
- Fish oil was administered at 2 g/kg body weight (≈540 mg/g EPA and 100 mg/g DHA) three times weekly for eight weeks.
- Treated rats showed lower insulin resistance, better blood glucose control, reduced inflammatory markers, and improved cholesterol, LDL, and triglyceride levels.
- Omega‑3 fatty acids are identified as a promising anti‑inflammatory strategy for non‑obese type 2 diabetes, warranting further investigation.
Why it matters: Non‑obese type 2 diabetes patients gain a research‑backed anti‑inflammatory approach, as fish oil cut insulin resistance in a rat model, reshaping therapeutic research and nutraceutical market focus.
Ask SkimNews
